Cidel Asset Management Inc. Acquires 191 Shares of Danaher Corporation $DHR

Cidel Asset Management Inc. boosted its holdings in Danaher Corporation (NYSE:DHRFree Report) by 9.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,146 shares of the conglomerate’s stock after purchasing an additional 191 shares during the period. Cidel Asset Management Inc.’s holdings in Danaher were worth $424,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Nuveen LLC bought a new position in Danaher during the 1st quarter worth approximately $833,941,000. Invesco Ltd. boosted its stake in shares of Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock valued at $965,259,000 after purchasing an additional 1,450,703 shares during the period. Baird Financial Group Inc. grew its holdings in shares of Danaher by 290.6% in the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after purchasing an additional 1,072,617 shares during the last quarter. Generation Investment Management LLP increased its stake in shares of Danaher by 33.2% in the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock worth $651,515,000 after buying an additional 791,662 shares during the period. Finally, Parnassus Investments LLC increased its stake in shares of Danaher by 23.3% in the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock worth $784,745,000 after buying an additional 722,636 shares during the period. 79.05% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 11.20% of the stock is currently owned by insiders.

Danaher Trading Down 0.8%

DHR opened at $209.14 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $275.51. The stock has a market cap of $149.76 billion, a PE ratio of 44.50, a PEG ratio of 2.98 and a beta of 0.77. The business has a 50 day moving average of $201.60 and a 200-day moving average of $197.24.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the company posted $1.72 EPS. Danaher’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is currently 27.23%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on DHR. Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Robert W. Baird increased their target price on shares of Danaher from $229.00 to $236.00 and gave the stock an “outperform” rating in a report on Wednesday, October 15th. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 target price (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $245.00.

Get Our Latest Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.